BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20190206T120000 DTEND;TZID=America/New_York:20190206T130000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:February Luncheon DESCRIPTION:ONLINE REGISTRATION IS NOW CLOSED FOR THIS EVENT. WALK-INS ARE WELCOME AT THE DOOR FOR A FEE OF $50.Join Venture Connectors on Wednesday\, Feb. 6\, to hear the inspiring success story of Crestwood\, Ky.-based Apellis Pharmaceuticals Inc. from President and CEO Cedric Francois\, MD\, PhD. He will share his experiences with taking the pharmaceutical company public\, as well as finding/attracting talent and securing funding. Dr. Francois will also share his perspective on changes in the local entrepreneurial climate during the past decade.Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases. Dr. Francois co-founded the company in September 2009\, and it now has clinical and manufacturing operations all over the world. X-ALT-DESC;FMTTYPE=text/html:
ONLINE REGISTRATION IS NOW CLOSED FOR THIS EVENT. WALK-INS ARE WELCOME AT THE DOOR FOR A FEE OF $50.
Join Venture Connectors on Wednesday\, Feb. 6\, to hear the inspiring success story of Crestwood\, Ky.-based Apellis Pharmaceuticals Inc. from President and CEO Cedric Francois\, MD\, PhD. He will share his experiences with taking the pharmaceutical company public\, as well as finding/attracting talent and securing funding. Dr. Francois will also share his perspective on changes in the local entrepreneurial climate during the past decade.
Apellis is a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds for the treatment of a broad range of life-threatening or debilitating autoimmune diseases. Dr. Francois co-founded the company in September 2009\, and it now has clinical and manufacturing operations all over the world.
LOCATION:144 N. Sixth St. Louisville KY 40202 UID:e.857.74414 SEQUENCE:3 DTSTAMP:20240329T084815Z URL:https://members.ventureconnectors.org/eventcalendar/Details/february-luncheon-84803?sourceTypeId=Hub END:VEVENT END:VCALENDAR